CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 144 target
Drug / intervention
hCG-IBSAdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00335569
NCT00335569Phase 3Completed
CompareCT.gov

A Prospective, Randomized, Controlled Clinical Study on the Assessment of Tolerance and Clinical Equivalence of hCG- IBSA (IBSA) Versus Ovitrelle (Serono), Both Administered Sub-cutaneously in Women Undergoing in Vitro Fertilization (IVF).

IBSA Institut Biochimique SA·interventional·Posted Jun 12, 2006·Updated Jun 1, 2011

In Brief

A Phase 3 clinical trial evaluating hCG-IBSA for Infertility. Completed, enrolled 144 participants across 4 sites.

Detailed Summary

The purpose of the study is to evaluate the clinical equivalence and the general tolerability of two different subcutaneous hCG preparations (hCG-IBSA, IBSA vs Ovitrelle, Serono) when administered to patients undergoing IVF.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesSwitzerland
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 12, 2006
Enrollment StartAug 1, 2005
Study CompletionDec 1, 2008
TodayJul 2, 2026
Posted 20.1 years ago

Interventions

hCG-IBSAdrug